Apollo Commercial Real Estate Finance, Inc.
ARI NYSE Real Estate Investment Trusts Financials FY2016βFY2025
What Apollo Commercial Real Estate Finance, Inc. does
No business description yet.
- Legal name
- Apollo Commercial Real Estate Finance, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 10, 2026
- Accession Β· CIK
- 0001193125-26-044725
0001467760
Revenue and margins
Apollo Commercial Real Estate Finance, Inc. had $272M of revenue in fiscal 2025, down 10.6% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β8.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Apollo Commercial Real Estate Finance, Inc. returned $141M to shareholders in fiscal 2025. The diluted share count fell 0.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Apollo Commercial Real Estate Finance, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $343M | $222M | $225M | $317M | $140M |
| Total assets | $8.4B | $9.6B | $9.3B | $8.4B | $9.9B |
| Total liabilities | $6.1B | $7.2B | $7.1B | $6.5B | $8.0B |
| Shareholders' equity | $2.3B | $2.4B | $2.2B | $1.9B | $1.9B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | 1.0% | 1.0% | β1.0% | β0.7% | β2.1% | 0.3% | β0.0% | β2.3% | β3.6% | β0.2% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $201M | $260M | $289M | $334M | $279M | $285M | $304M | $345M | $304M | $272M |
| Net interest income | $201M | $260M | $289M | $334M | $279M | $266M | $242M | $252M | $199M | $167M |
| Provision for credit losses | $15.0M | $5.0M | $20.0M | $20.0M | β | β | β | β | β | β |
| Interest expense | $63.8M | $78.1M | $115M | $153M | $149M | $163M | $271M | $466M | β | β |
| Pretax income | β | β | β | β | β | $224M | $265M | $58.6M | β$119M | $127M |
| Income tax | β | β | β | β | β | $0.0M | $0.0M | $0.4M | $0.4M | $0.3M |
| Net income | $158M | $193M | $220M | $230M | $18.4M | $224M | $265M | $58.1M | β$120M | $127M |
| Net income to common | $128M | $156M | $193M | $212M | $4.8M | $211M | $253M | $45.9M | β$132M | $114M |
| Diluted EPS | $1.74 | $1.54 | $1.48 | $1.40 | $0.01 | $1.46 | $1.68 | $0.29 | β$0.97 | $0.81 |
| Diluted shares | 0.07B | 0.10B | 0.15B | 0.18B | 0.15B | 0.17B | 0.17B | 0.14B | 0.14B | 0.14B |
| Cash flow | ||||||||||
| Cash from operations | $124M | $155M | $266M | $273M | $164M | $199M | $268M | $274M | $200M | $143M |
| Depreciation and amortization | β | β | β | $0.0M | $0.0M | $2.6M | $0.7M | $8.2M | $11.7M | $11.2M |
| Stock-based compensation | $4.5M | $11.0M | $8.8M | $15.9M | $16.8M | $17.6M | $18.3M | $17.4M | $16.5M | $13.6M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $128M | $0.0M | $0.0M | $0.0M | $40.8M | $0.0M |
| Dividends paid | $132M | $184M | $227M | $269M | $238M | $200M | $201M | $202M | $186M | $141M |
| Dividends and buybacks | $132M | $184M | $227M | $269M | $366M | $200M | $201M | $202M | $227M | $141M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $201M | $77.7M | $110M | $452M | $325M | $343M | $222M | $225M | $317M | $140M |
| Loans, net | β | β | β | β | β | β | β | $694M | $487M | $313M |
| Total assets | $3.5B | $4.1B | $5.1B | $6.9B | $6.9B | $8.4B | $9.6B | $9.3B | $8.4B | $9.9B |
| Total liabilities | $1.6B | $2.0B | $2.6B | $4.3B | $4.7B | $6.1B | $7.2B | $7.1B | $6.5B | $8.0B |
| Preferred stock | β | β | β | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M |
| Shareholders' equity | $1.9B | $2.1B | $2.5B | $2.6B | $2.3B | $2.3B | $2.4B | $2.2B | $1.9B | $1.9B |
| Margins | ||||||||||
| Net margin | 78.7% | 74.1% | 76.0% | 68.8% | 6.6% | 78.6% | 87.4% | 16.9% | β39.4% | 46.7% |
| Net interest share of revenue | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 93.4% | 79.6% | 73.2% | 65.5% | 61.4% |
| Returns | ||||||||||
| Return on equity | 8.2% | 9.6% | 9.6% | 9.0% | 0.8% | 9.8% | 11.4% | 2.5% | β5.9% | 6.8% |
| Return on assets | 4.5% | 5.1% | 4.8% | 3.8% | 0.3% | 2.9% | 2.9% | 0.6% | β1.4% | 1.4% |
| Return on tangible equity | 6.6% | 7.5% | 7.7% | 8.0% | 0.2% | 9.2% | 10.7% | 2.1% | β7.0% | 6.2% |
| Growth | ||||||||||
| Revenue growth | β | 29.8% | 11.1% | 15.6% | β16.7% | 2.1% | 6.7% | 13.5% | β11.9% | β10.6% |
| Net income growth | β | 22.3% | 14.0% | 4.6% | β92.0% | 1,116.3% | 18.7% | β78.1% | β305.8% | β |
| EPS growth | β | β11.5% | β3.9% | β5.4% | β99.3% | 14,500.0% | 15.1% | β82.7% | β434.5% | β |
| Share count change | β | 38.1% | 51.9% | 14.3% | β15.8% | 13.8% | β1.7% | β14.6% | β1.1% | β0.6% |
| Capital allocation | ||||||||||
| Stock comp / revenue | 2.2% | 4.2% | 3.0% | 4.8% | 6.0% | 6.2% | 6.0% | 5.1% | 5.4% | 5.0% |
| Quality scores | ||||||||||
| Accruals ratio | 1.0% | 1.0% | β1.0% | β0.7% | β2.1% | 0.3% | β0.0% | β2.3% | β3.6% | β0.2% |
Source: SEC EDGAR XBRL filings (CIK 0001467760). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.